of antigenic markers
these markers have either been assessed or an assessment is
planned in the near future.
marker to see a characterization of the proteins, their
occurrence in neoplastic cells, the diagnostic application of
the markers, aspects of visualization including controls, and results of NordiQC
schemes and protocols.